Search

everythinglearnresearchcommunity

for

Search:↓

Gene variation affects prostate issues and hair loss.

CEC levels may be a useful marker for predicting prostate cancer progression.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Hair loss gene linked to prostate issues.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dutasteride may help shrink prostate cancer tumors.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Certain drugs that block specific enzymes can help treat prostate diseases.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Suppressing certain hormones might help prevent prostate cancer.